The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04296890
Brief Title: A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (SORAYA)

First Submitted : February 27, 2020
First Submitted that Met QC Criteria : March 3, 2020
First Posted : March 5, 2020

Certification/Extension First Submitted : September 16, 2022
Certification/Extension First Submitted that Met QC Criteria : September 16, 2022
Certification/Extension First Posted : September 21, 2022

Last Update Submitted that Met QC Criteria : July 21, 2023
Last Update Posted : July 25, 2023